still bleeding hard, no takeout with this downfallstill bleeding hard, no takeout with this downfall, generally most stocks on a buyout tend to have high volume and an increase in price, with this bloody stock this is not the case, delay in the assays is also not helping the share price,seems also lack of confidence in management, thats my bloody opinion,dueyour own due dilgence